Evotec SE (EVO) Inventory (2009 - 2026)

Evotec SE (EVO) posted Inventory of $38613.5 for Q1 2026, up 13.15% sequentially from $34126.3 in Q4 2025, and up 9.55% YoY from $35246.5 in Q1 2025.

Evotec SE (EVO) Inventory (2009 - 2026) Analysis & Trends

Evotec SE has reported Inventory for 9 years, with the latest figure at $38613.5 in Q1 2026.

Quarterly Inventory rose 9.55% year-over-year to $38613.5 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $38613.5 (up 9.55% YoY) and the FY2025 annual result came in at $34126.3, down 99.9% from the prior year.
Inventory grew to $38613.5 in Q1 2026 per EVO's latest filing, from $34126.3 in the prior quarter.
Over five years, Inventory peaked at $33.3 million in Q4 2024 and troughed at $29266.1 in Q1 2022.
A 5-year average of $8.1 million and a median of $37534.7 in 2025 frame the typical range for Inventory.
The sharpest annual moves came in 2022 and 2025: Inventory increased 17.22% in 2022, then tumbled 99.9% in 2025.
Over 5 years, Inventory stood at $30.4 million in 2022, then rose by 9.22% to $33.2 million in 2023, then gained by 0.06% to $33.3 million in 2024, then sank by 99.9% to $34126.3 in 2025, then climbed by 13.15% to $38613.5 in 2026.
According to Business Quant data, Inventory over the past three periods registered $38613.5, $34126.3, and $36455.8 for Q1 2026, Q4 2025, and Q3 2025 respectively.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Inventory (Qtr)
1	Haleon	43.83 Bn	42.86 Bn	-	1.44 Bn
2	Teva Pharmaceutical Industries	42.87 Bn	39.22 Bn	2.15 Bn	3.22 Bn
3	Zoetis	31.41 Bn	29.73 Bn	1.05 Bn	2.57 Bn
4	Takeda Pharmaceutical	28.55 Bn	22.75 Bn	5.10 Bn	9.08 Bn
5	United Therapeutics	22.08 Bn	19.42 Bn	683.80 Mn	193.80 Mn
6	Viatris	18.73 Bn	17.84 Bn	1.46 Bn	3.93 Bn
7	Neurocrine Biosciences	15.44 Bn	15.05 Bn	935.80 Mn	104.20 Mn
8	Elanco Animal Health	11.75 Bn	11.22 Bn	798.00 Mn	1.77 Bn
9	Dr Reddys Laboratories	10.11 Bn	9.94 Bn	-	816.00 Mn
10	Evotec SE	692.56 Mn	692.08 Mn	-	38,613.53

Download Data